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Abstract
Acidification is required for the function of many intracellular organelles, but methods to acutely 
manipulate their intraluminal pH have not been available. Here we present a targeting strategy to 
selectively express the light-driven proton pump Arch3 on synaptic vesicles. Our new tool, 
pHoenix, can functionally replace endogenous proton pumps, enabling optogenetic control of 
vesicular acidification and neurotransmitter accumulation. Under physiological conditions, 
glutamatergic vesicles are nearly full, as additional vesicle acidification with pHoenix only slightly 
increased the quantal size. By contrast, we found that incompletely filled vesicles exhibited a 
lower release probability than full vesicles, suggesting preferential exocytosis of vesicles with high 
transmitter content. Our subcellular targeting approach can be transferred to other organelles, as 
demonstrated for a pHoenix variant that allows light-activated acidification of lysosomes.
The release of neurotransmitters from synaptic vesicles is a key element of chemical 
synaptic transmission. Synaptic vesicle recycling after exo- and endocytosis requires 
neurotransmitter uptake by specialized vesicular transporter proteins1. The electrochemical 
driving force for neurotransmitter accumulation is generated by vacuolar-type H+-ATPases 
(V-ATPases) that actively transport cytosolic protons into the synaptic vesicle lumen, thereby 
acidifying the vesicles and generating an inside positive membrane potential2. V-ATPases 
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also acidify other subcellular compartments of the secretory and endocytic pathways such as 
endosomes, Golgi-derived vesicles and lysosomes, but to a different extent, with lysosomes 
being the most acidic compartments in a cell (pH < 5)3. The tightly regulated acidification 
of these organelles is a prerequisite for a plethora of different processes including 
processing, storage and degradation of proteins, lipids, and polysaccharides3,4. However, 
elucidating the physiological roles of V-ATPases has remained challenging due to the lack of 
tools that allow rapid and compartment-specific control of proton accumulation.
The recent advance of optogenetic methods allows for precise manipulation of multiple 
cellular activities with light. In neuroscience, microbial rhodopsins such as 
channelrhodopsins and light-activated ion pumps are applied to modulate the neuronal 
membrane potential, thereby tuning excitability5–7. Cell-type specific expression of such 
actuators is commonly achieved by combining sophisticated expression systems with 
specific promoters8, but only few publications report cell compartment-specific expression 
of optogenetic actuators, including expression in the postsynaptic density9, in dendrites10 
and in axon initial segments11,12. While these tools allow manipulation of the local plasma 
membrane potential, optogenetic tools to control the ion and voltage gradients across 
intracellular membranes in neurons have not been developed to date. Here we report a 
strategy to express the light-activated proton pump Archaerhodopsin-3 (Arch3)7,13 from 
Halorubrum sodomense on synaptic vesicles, together with the pH-sensitive GFP variant 
pHluorin as sensor for vesicular pH14. The fusion protein, named pHoenix, enables 
controlling and monitoring acidification of synaptic vesicles by yellow and blue light, 
respectively. We applied pHoenix in order to manipulate the neurotransmitter content of 
synaptic vesicles and to investigate the interplay of vesicle content and exocytosis. First, we 
found that additional optogenetic acidification slightly increases EPSC amplitudes, as well 
as quantal size. Second, we assessed whether insufficient filling of glutamatergic vesicles 
affects release probability. After pharmacological depletion of the synaptic vesicle content, 
we subsequently employed pHoenix for optically controlled re-acidification and restoration 
of transmitter uptake, and found that insufficiently filled vesicles fuse with a lower 
probability. Based on the modular design of pHoenix, we also created a variant targeting 
lysosomes, enabling external control of lysosomal acidification.
Results
Targeting Arch3 onto synaptic vesicles
In order to functionally express a light-activated proton pump in the synaptic vesicle 
membrane, we incorporated Arch3 between helix three and four of the vesicular protein 
synaptophysin, together with the fluorescent proteins mKate2 on the cytosolic and pHluorin 
on the luminal side to indicate protein expression and localization as well as luminal 
acidification. As the C-terminus of Arch3 is located on the cytosolic side13, while the fourth 
synaptophysin helix originates in the vesicle lumen, we added the transmembrane helix of 
the rat gastric H+/K+ ATPase beta-subunit (ŚHK) to maintain the transmembrane topology15 
(Fig. 1a, Supplementary Fig. 1a,b).
We expressed the resulting fusion protein, pHoenix, in mouse hippocampal neurons using 
lentivirus. After two weeks in culture, pHoenix was enriched at presynaptic terminals and 
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colocalized with the vesicular glutamate transporter 1 (VGLUT1), which was not the case 
for untargeted Arch3-eGFP (Fig. 1b). During whole-cell patch clamp recordings, 1 s light 
pulses evoked 250 times smaller somatic outward currents in pHoenix-expressing neurons 
compared to neurons expressing Arch3-eGFP (Fig. 1c), indicating that pHoenix is mostly 
retained intracellularly. Indeed, optical quantification of surface-resident pHluorin molecules 
(Supplementary Fig. 1c,d) revealed that only 15% of the pHoenix proteins reside in the 
plasma membrane (Fig. 1d), similarly to synaptophysin-pHluorin (sypHy), a well-
established indicator of vesicular pH and synaptic transmission14. Furthermore, bursts of 60 
action potentials (APs) at 20 Hz triggered an increase of pHluorin fluorescence due to 
exocytosis of synaptic vesicles in pHoenix-expressing neurons (Fig. 1e), demonstrating 
proper integration of the construct into synaptic vesicles. Notably, expression of pHoenix did 
not interfere with basic neuronal release parameters (Supplementary Fig. 2).
Light-driven acidification of synaptic vesicles by pHoenix
V-ATPases acidify newly formed synaptic vesicles after their endocytosis from the 
presynaptic plasma membrane, providing the proton-motive force that drives the 
neurotransmitter uptake by specialized antiporters such as the vesicular glutamate 
transporters VGLUT1–316. In order test whether pHoenix can functionally substitute for the 
activity of the endogenous proton pumps, we blocked vesicular acidification and transmitter 
uptake by incubating cultured hippocampal neurons grown on microislands with the V-
ATPase inhibitor bafilomycin A1 (Baf). We then monitored pHluorin signals in 
glutamatergic neurons to follow vesicle acidification and, in parallel, recorded excitatory 
postsynaptic currents (EPSCs), which indicated the level of vesicular transmitter filling. 
Preincubation with 1 µM Baf for 2–5 h depleted the proton gradient over vesicular 
membranes and resulted in strong pHluorin fluorescence at synaptic terminals (Fig. 2a), with 
no or very small EPSCs evoked by APs (Fig. 2b). pHoenix activation with 580 nm light for 2 
minutes resulted in a biphasic fluorescence decrease, with an immediate drop to 70% within 
the first 5 s, reflecting fast vesicle acidification, followed by a slower decay to 60% (Fig. 
2a,c). Simultaneously recorded EPSCs recovered with a time constant Ŭ = 58 s (Fig. 2b,c). 
Control experiments in neurons expressing sypHy showed that bleaching of pHluorin-
molecules could not account for the rapid decrease of fluorescence (Supplementary Fig. 3). 
Thus, pHoenix activity is sufficient to rapidly acidify synaptic vesicles, allowing the control 
of vesicular transmitter uptake with light.
We further tested the applicability of pHoenix in organotypic brain slices. Adeno-associated 
virus encoding pHoenix was injected into area CA3 after three to five days in vitro 
(Supplementary Fig. 4a). At >14 days post-infection, we incubated slices with 1 µM Baf 
overnight, which caused strong pHluorin signals (Supplementary Fig. 4b), and effectively 
abolished EPSCs. pHoenix activation for 2 min recovered synaptic transmission at 
associational-commissural fiber synapses (Supplementary Fig. 4c,d), illustrating that the use 
of pHoenix can also be extended to brain slice preparations and possibly in vivo 
applications.
Refilling of synaptic vesicles by pHoenix should create a finite pool of vesicles that could be 
subsequently depleted by AP-triggered exocytosis. Indeed, following 2 min of illumination 
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and pHoenix-mediated recovery of transmission, repetitive stimulation with trains of APs 
(600 APs over 300 s), but not sparse stimulation (30 APs in 300 s), rapidly reduced EPSC 
amplitudes in autaptic cultures of glutamatergic neurons (Supplementary Fig. 5). 
Accordingly, pHluorin signals strongly increased under the train stimulation due to 
exhaustive exocytosis and failure of re-acidification. A second illumination period caused re-
quenching of pHluorin signals, while synaptic transmission recovered, illustrating that 
optogenetic vesicle acidification and transmitter uptake is fully reversible by AP-driven 
exocytosis.
The observed rescue of transmission in Baf-treated neurons was pHoenix-specific: While 
light-induced EPSC recovery in pHoenix-expressing cells yielded EPSCs of 3.1 ± 0.6 nA, 
illumination failed to rescue EPSCs in control cells expressing Arch3-eGFP (Supplementary 
Fig. 6a). Rescued EPSCs of Baf-treated neurons reached amplitudes comparable to those of 
EPSCs of untreated cells from the same culture (Supplementary Fig. 6b). Importantly, the 
frequency and amplitude of spontaneous miniature EPSCs (mEPSCs), which reflect the 
stochastic fusion of single vesicles, did not differ between the two groups (Supplementary 
Fig. 6c). Thus, the light-driven pHoenix activity can achieve vesicular transmitter filling 
comparable to endogenous V-ATPases.
Superfilling of synaptic vesicles by pHoenix activity
EPSCs of untreated neurons expressing pHoenix slightly increased during illumination 
(Supplementary Fig. 6b). We characterized this effect in detail by comparing pHoenix-
expressing neurons with control neurons (uninfected or sypHy-infected). Activation of 
pHoenix increased EPSC amplitudes by 13 ± 2%, an effect not seen in controls (Fig. 3a). We 
directly assessed the release probability in these cells by using a 40 ms paired pulse 
stimulation paradigm, where a low ratio of the second to first EPSC amplitude indicates a 
high release probability17. The light-induced change in the paired-pulse ratio (PPR) was not 
significantly different between the two groups (Fig. 3b), thus the increase of EPSC 
amplitudes was probably not due to a higher release probability. Likewise, illumination did 
not have a differential effect on the mEPSC frequency (Fig. 3c). However, illumination 
caused a significant increase of mEPSCs amplitudes by 11 ± 2% (Fig. 3d) in pHoenix-
expressing cells. Our experiments suggest that light-activated proton pumping by pHoenix 
provides an additional driving force for vesicular transmitter accumulation, reflected by 
larger postsynaptic responses (Fig. 3e), but the relatively small effect on both EPSC and 
mEPSC amplitudes implies that vesicles are nearly filled to maximal storage capacity under 
physiological conditions.
Partially filled vesicles have a lower release probability
Reliable synaptic transmission requires exocytosis of synaptic vesicles loaded with sufficient 
levels of neurotransmitter molecules. However, whether incomplete vesicular filling affects 
vesicle release probability is still under debate. In fact, some experimental findings showed 
that the vesicular fill state influences vesicle release probability18,19, while others 
demonstrated equally efficient release of empty vesicles20,21. The ability to control 
transmitter uptake into vesicles by light-driven proton pumping allowed us to directly assess 
the relation of vesicular transmitter content and vesicular release probability. We 
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investigated transmitter release of autaptic neurons that still exhibited small, residual EPSCs 
after >2 h incubation in Baf and compared it to the restored release after pHoenix activation 
(Fig. 4a). pHoenix-driven transmitter uptake increased mEPSC amplitudes by 70%, while 
mEPSC frequency increased more than tenfold (Fig. 4b). The small initial mEPSC 
amplitudes imply that residual EPSCs rely on vesicles only partially filled with glutamate. 
Notably, the PPR decreased by 40% during the pHoenix-mediated EPSC recovery (Fig. 4c), 
indicating that vesicular release probability increases with vesicular filling. The 
incrementing release of glutamate could lead to a progressive desensitization of postsynaptic 
AMPA receptors, which might contribute to changes in the PPR22. However, in the presence 
of cyclothiazide, an antagonist of AMPA receptor desensitization, we observed a comparable 
decrease in PPR (Supplementary Fig. 7), ruling out that in our experimental conditions the 
increased vesicular content enhances receptor desensitization.
The high PPR of residual EPSCs might result from the release of a pool of “release-
reluctant” vesicles that were not discharged during the incubation with Baf because of their 
intrinsically low release probability. As pHoenix activity promotes gradual filling of synaptic 
vesicles, we were able to titrate the vesicular glutamate content more accurately using a two-
step recovery protocol: In cells devoid of transmission after Baf treatment, we applied a 30 s 
non-saturating light pulse that caused only partial recovery of the evoked response, followed 
by a dark phase of 60 s and a second saturating light pulse for 90 s (Fig. 5a). This protocol 
allowed us to compare an intermediate fill state with reduced postsynaptic responses to the 
condition with full vesicles after final EPSC recovery. In the intermediate fill state, EPSCs 
remained stable, at 37% of the final amplitude, while pHluorin signals increased slightly due 
to AP-triggered exocytosis (Supplementary Fig. 8). This illustrates that VGLUTs require 
constant proton pumping for transmitter uptake. Using two independent approaches we 
verified that the non-saturating light pulse created partially filled vesicles: First, analysis of 
spontaneous release revealed that mEPSC amplitudes were 25% smaller and occurred at a 
42% lower frequency compared to the full recovery state (Fig. 5b). Second, we tested the 
effectiveness of the low-affinity, competitive AMPAR antagonist ś-D-glutamylglycine (ś-
DGG) on attenuating EPSCs, which has been established as an indicator for the amount of 
vesicular glutamate released by exocytosis23: A strong reduction of EPSCs by ś-DGG 
reflects a low vesicular glutamate content, while the ś-DGG effect decreases with increasing 
amounts of glutamate released. We found that after the non-saturating light interval, ś-DGG 
decreased EPSCs to 31%, while EPSCs were reduced to only 40% after the second, 
saturating light interval (Fig. 5c). Both observations support the idea that the reduced 
postsynaptic responses in the intermediate recovery are based on a partial vesicular fill state. 
How does partial transmitter filling affect the release probability? Paired-pulse 
measurements showed a 10% higher PPR in the intermediate recovery state compared to the 
full state (Fig. 5d), indicating a lower release probability of partially filled vesicles. We also 
assessed the readily releasable pool (RRP) of synaptic vesicles by brief applications of 
hypertonic sucrose solutions during the intermediate and the final recovery state (Fig. 5e,f), 
which allowed us to directly calculate the vesicular release probability (Pvr)24. During the 
intermediate recovery state the RRP was 60% smaller compared to the final recovery state 
(Fig. 5g,i). The Pvr of partially filled vesicles was 14% lower compared to vesicles after 
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complete filling (Fig. 5h,i), and the vesicular fill state correlated with the pool size and Pvr 
(Fig. 5j). Thus, insufficient vesicular filling reduces the vesicular release probability.
Light-driven acidification of lysosomes
The modular pHoenix design provides a blueprint for specific intracellular trafficking of 
both Arch3 and fluorescent indicators. Consequently, we modified pHoenix to target 
lysosomes by insertion of the pHluorin-Arch3-mKate-ŚHK construct between helix 1 and 2 
of the tetraspanin CD63, a lysosomal marker protein25 (Fig. 6a). The resulting “lyso-
pHoenix” showed strong co-labeling with the lysosome-associated membrane protein 2 
(LAMP2), but not with markers for the Golgi apparatus, endoplasmic reticulum, endosome, 
or mitochondria, demonstrating specific expression on lysosomal membranes (Fig. 6c, 
Supplementary Fig. 9). In Baf-treated HEK 293 cells, activation of lyso-pHoenix by 580 nm 
light caused a rapid decrease of pHluorin signals, indicating a drop in pH, which was not 
seen in control cells expressing CD63-pHluorin. Remarkably, lysosomal acidification 
required constant proton pumping, as pHluorin signals quickly recovered after termination 
of lyso-pHoenix activation, suggesting a strong proton leak in lysosomes (Fig. 6d).
Discussion
Light-driven proton pumps are powerful tools for silencing neuronal activity, as they 
hyperpolarize the plasma membrane by exporting protons from the cytosol to the 
extracellular side of the membrane26. Interestingly, only few studies have exploited their 
potential to alter the pH of intracellular organelles. In yeast, the light-driven proton pump 
bacteriorhodopsin from Halobacterium salinarium has been successfully targeted to the inner 
mitochondrial membrane27. In cell-free assays, bacteriorhodopsin from Halobacterium 
halobium has been employed to acidify proteoliposomes in order to study the proton-
dependence of VGLUT-driven glutamate uptake28, but similar experiments have not yet 
been feasible in living neurons. Our new tool, pHoenix, now allows precise temporal control 
of the acidification process of synaptic vesicles, and will enable studies on synaptic vesicle 
biogenesis and neurotransmitter uptake in living neurons.
Two parameters affect the vesicular transmitter filling: the proton gradient and the number 
and activity of vesicular transmitter transporters. Experimentally, the vesicular transmitter 
content can be manipulated in two ways – either by altering the number of active vesicular 
transmitter transporters19,29–31, or by alteration of the proton electrochemical 
gradient20,21. To our knowledge, pHoenix is the first tool enabling acute increase of the 
vesicular proton-gradient. In cells with intact V-ATPase function, additional optogenetic 
acidification increased both EPSC and mEPSC amplitudes by more than 10%. The ability of 
pHoenix to increase the vesicular glutamate filling beyond the filling capacity provided by 
V-ATPases demonstrates that Arch3 generates a proton motive force that exceeds the driving 
force provided by endogenous V-ATPases, indicating that the proton transport properties of 
V-ATPases limit the amount of glutamate uptake. The EPSC and mEPSC amplitude increase 
by pHoenix activation in untreated neurons also implies that activation of surface resident 
pHoenix does not cause significant synaptic cleft acidification, which would impair synaptic 
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transmission by inhibiting presynaptic calcium influx through voltage gated calcium 
channels32.
In Baf-treated neurons, refilling of vesicles by interval illumination revealed that glutamate 
uptake requires constant proton pumping (Supplementary Fig. 8). While pH remained low, 
glutamate uptake stopped immediately after light off and cessation of pHoenix activity. This 
is strong evidence for the notion that membrane voltage and not the pH gradient is the 
driving-force for VGLUT-mediated transmitter uptake2. The absence of proton leakage and 
stable synaptic transmission during low-frequency stimulation indicates that both low 
luminal pH and transmitter content of glutamatergic synaptic vesicles are preserved even in 
the absence of V-ATPase function, arguing against a steady-state model of transmitter uptake 
and leak in synaptic vesicles33. This is not the case for lysosomes, where the pH increased 
again within seconds after terminating the lyso-pHoenix-mediated acidification, 
demonstrating constant lysosomal proton leakage.
Our experiments further revealed that partially filled neurotransmitter vesicles can be 
released, proving that exocytosis is not guarded by a rigid fill-state control mechanism. 
However, incompletely filled vesicles do have a lower release probability. The underlying 
mechanism for this observation is not clear, but it seems likely that proton pumping and 
transmitter accumulation increase intravesicular osmolarity, which leads to a higher vesicle 
membrane tension and increases fusion probability with the plasma membrane. Electron 
microscopy studies revealed that synaptic vesicles of VGLUT1 deficient neurons were 
deformed in contrast to vesicles from wildtype neurons, suggesting that failure of transmitter 
uptake (but not failure of acidification) renders them more labile19,34. Moreover, filled 
vesicles were found to exhibit a larger diameter than empty vesicles35,36. Interestingly, the 
PPR changed faster than EPSCs increased, both at high (Fig. 4) and low illumination 
intensity (Supplementary Fig. 7), indicating that the threshold for a high Pvr defined by 
intravesicular osmolarity and membrane tension is reached before the maximal vesicular 
transmitter storage capacity. In line with this, we observed no further increase of the release 
probability when we used pHoenix in untreated cells to further increase vesicular filling 
(Fig. 3). The preferential release of completely filled vesicles could be of relevance for 
synaptic information processing: During sustained neuronal firing and high turnover of 
vesicles, this mechanism might assure efficient postsynaptic receptor activation and reliable 
synaptic transmission.
As pHoenix can functionally replace V-ATPases, it can be applied to rescue the cellular 
degeneration observed in V-ATPase KO models in yeast37, Drosophila38, and mice39. 
Recent studies suggested that V-ATPases have acidification-independent functions as 
vesicular pH-sensors40, interaction partners of SNARE proteins41, and may participate 
directly in synaptic vesicle fusion42. In combination with pump activity-deficient V-ATPase 
mutants43, pHoenix will facilitate structure–function analyses of V-ATPases and help to 
elucidate their non-canonical roles.
Optogenetic organelle acidification allows to investigate quantitative aspects of proton-
dependent transport and to study the properties of organelles as a function of their 
intraluminal pH. To further pursue this goal we aimed to develop a variant with opposing 
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function to pHoenix by replacing Arch3 by a channelrhodopsin with high proton 
conductance in order to deplete proton gradients using light. Unfortunately, all tested 
channelrhodopsin-derived pHoenix variants were ineffective (data not shown), probably 
because the multimerization properties of channelrhodopsins and microbial pumps differ44–
46. In line with this, a pHoenix-based actuator that allows manipulation of circuit activity 
will require further developments of the construct.
Whereas the transfer of the pHoenix concept to other microbial-type rhodopsins has proven 
unsuccessful to date, we were able to target a pHoenix variant to a different subcellular 
compartment by replacing the synaptophysin parts in pHoenix with the lysosomal CD63 
protein. The resulting lyso-pHoenix can be applied to specifically investigate the pH-
dependency of the catabolic processes confined to lysosomes, e.g. the acid-dependent 
activity of lysosomal proteases47. Notably, alterations in organelle pH-homeostasis due to 
defects in proton translocation or counterion conductances are associated with many 
different pathophysiological conditions48, ranging from cancer49 to neurodegeneration50. 
The here presented pHoenix-constructs may provide a new approach for directly assessing 
the role of acidification in these disorders.
Online Methods
Cloning strategy and virus production
To generate the pHoenix construct, we inserted Archaerhodopsin-3 (Arch3) from 
Halorubrum sodomense into the synaptophysin molecule. Since it has been reported that a 
sypHy version lacking the fourth transmembrane domain and thus the C-terminus of 
synaptophysin was incorrectly targeted in neurons51, we maintained the N- and C-terminus 
of synaptophysin as trafficking signals. First, we inserted a single transmembrane domain of 
the rat gastric H+/K+ ATPase beta-subunit52, which had previously been successfully used 
for tandem optogenetic constructs15, into the rat synaptophysin-pHluorin 2x (sypHy2) 
construct53 using Age I sites, thereby replacing the second superecliptic pHluorin molecule. 
Next, we amplified Arch3 cDNA (from Addgene clone 22222) by PCR. The fragment was 
inserted C-terminal to the super-ecliptic pHluorin using BamHI and SplI sites. Finally, the 
red fluorescent marker mKate254 was inserted at the cytosolic C-terminus of Arch3 via SplI 
and HindIII.
CD63 cDNA was generated by TA cloning from mouse whole brain mRNA and transferred 
into a mammalian expression vector with CMV promoter. As the large second luminal loop 
contains three potential N-linked glycosylation motives25, we introduced AfeI and SacI 
restriction sites into the first luminal loop as insertion site for the optogenetic cassette 
encoding pHluorin, Arch3, mKate2 and the rat gastric H+/K+ ATPase beta-subunit. In order 
to create CD63-pHluorin, the CD63-pHoenix construct was AgeI-digested, thereby 
removing Arch3, mKate2 and the H+/K+ ATPase beta-subunit, and religated. All constructs 
were verified by sequencing. Plasmids encoding pHoenix (Genbank accession number 
KT880224), lyso-pHoenix (Genbank accession number KT880225) and lyso-pHluorin 
(Genbank accession number KT880226) can be obtained via Addgene.
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Viral particles were provided by the Viral Core Facility (VCF) of the Charité Berlin. 
Lentivirus was produced according to published protocols55, with minor modifications: The 
coding sequences of pHoenix, sypHy (Addgene clone 24478) or Arch3-EGFP were 
transferred into a modified FUGW lentiviral expression vector55 with the neuron-specific 
human synapsin promoter. 20 Mg of the expression vector were cotransfected into HEK 
293T cells with 5 Mg each of the helper plasmids pCMVdR8.9 and pVSV.G using X-
tremeGENE 9 DNA transfection reagent (Roche). Lentiviral particles were harvested from 
cultures maintained in Neurobasal-A supplemented with 2% B27 and 0.2% penicillin/
streptomycin (all cell culture media from Invitrogen) at 32 °C and 5% CO2 for 72 h. 
Supernatants were filtered and subsequently 20x concentrated using Amicon Ultra-15 
centrifugal 10 kDa filter units. Aliquots of the lentivirus were shock-frozen and stored at –
80 °C. Adeno-associated virus (AAV) serotype 9 was produced in HEK293 cells transfected 
with polyethylenimine (PEI) and the following plasmids: pAD deltaF6, pAAV2/9 (both from 
Penn Vector Core, University of Pennsylvania) and an AAV expression vector encoding 
pHoenix under the human synapsin promoter. After 48 h, cells were resuspended, collected 
by centrifugation and lysed in 50 mM Tris-Cl, 150 mM NaCl. Viral particles were purified 
using an iodixanol gradient purification process according to published protocols56 and 
stored at 4 °C.
Cell culture
Animals were handled in accordance with the regulations of local authorities and the animal 
welfare committee of the Charité – Universitätsmedizin Berlin, Germany.
Autaptic cultures of primary hippocampal neurons: Low-density cultures of hippocampal 
neurons on glia cell microislands57 were prepared from newborn C57/BL6-N mice of either 
sex as previously described58. Briefly, astrocytes were prepared from cortices and expanded 
in T75 bottles in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% 
fetal calf serum and 0.2% penicillin/streptomycin (Invitrogen). To obtain microisland 
cultures, coverslips were coated with a thin film of agarose. After drying the agarose, a 
pattern of 300 µm diameter spots of growth permissive substrate consisting of 0.7 mg ml−1 
collagen and 0.1 mg ml−1 poly-D-lysine was applied using a custom-made stamp. After 14 
days in vitro (DIV) astrocytes were seeded onto the glass coverslips at a density of 5000 
cm−2, and were allowed to proliferate in DMEM medium for one more week to form 
microislands. Medium was changed to Neurobasal-A supplemented with 2% B27 and 0.2% 
penicillin/ streptomycin 24 h before hippocampal neurons prepared from P0 mice were 
added at a density of 300 cm–2. Neurons were infected with lentiviral particles at DIV 1–2.
Cultures of HEK 293 and HeLa cells: Cell lines were maintained in DMEM supplemented 
with 10% fetal calf serum and 0.2% penicillin/streptomycin. For live-cell imaging and 
immunocytochemistry experiments, cells were seeded at low density onto coverslips coated 
with 0.7 mg ml–1 collagen and 0.1 mg ml–1 poly-D-lysine, transfected after 24 h using X-
tremeGENE 9 DNA transfection reagent according to the manufacturer’s instructions, and 
were used 24–48 h post transfection.
Hippocampal organotypic slice cultures: Wistar rat hippocampi were dissected from pups of 
either sex (postnatal day 5–8) in a sucrose-based solution and horizontal slices were cut 
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using a vibratome (Leica VT1200S). Slices were washed with sterile solution and plated on 
membrane inserts (0.4 µm Millicell, Millipore). Culture medium contained 50% Basal 
Medium Eagles (BME), 25% Hank’s balanced salt solution (HBSS), 25% heat-inactivated 
horse serum, 1 mM Glutamax I supplement (all from GIBCO), and 6.5 g/L D-glucose. 
Antibiotics were added 24 h after the preparation (penicillin/streptomycin). The medium 
was changed three times a week, no antimycotics were used. At DIV 3–5 slices were 
transduced under sterile conditions with an AAV encoding pHoenix using a 
micromanipulator. The tip of a baked pipette was filled with the AAV-containing solution 
and lowered into stratum pyramidale of area CA3 so that the virus could diffuse into the 
slice.
Electrophysiology
Experiments on autaptic neurons were performed at room temperature on an Olympus IX51 
inverted microscope equipped with a Multiclamp 700B amplifier under control of a Digidata 
1440 AD board and pClamp10 software (Molecular Devices). External solutions were 
applied using a custom-built rapid perfusion system58, while the bath level was controlled 
by an MPCU bath handler (Lorenz Messgerätebau, Katlenburg-Lindau, Germany). Whole-
cell recordings were performed between DIV14 and 21. Cells were voltage clamped at –70 
mV, with 70% compensation of series resistance and capacitance. Recordings were 
discarded when the series resistance exceeded 15 MOhm. To evoke EPSCs in autaptic 
neurons, unclamped action potentials were triggered by a 1-ms depolarization step to 0 mV. 
Spontaneous mEPSCs were analyzed from the same recordings in intervals starting 2 s after 
the action potential. Intracellular solution contained (in mM): 135 potassium gluconate, 17.8 
Hepes, 1 EGTA, 4.6 MgCl2, 4 Na2ATP, 12 creatine phosphate and 50 U/ml creatine 
phosphokinase, pH adjusted to 7.3 with KOH, 300 mOsm. Cells were continuously 
superfused with HEPES-buffered solution (in mM): 140 NaCl, 2.4 KCl, 10 HEPES, 10 
glucose, 2 CaCl2, and 4 MgCl2, pH adjusted to 7.3 with NaOH, 300 mOsm. The readily 
releasable pool was determined as the charge transient of the postsynaptic current evoked by 
a 5-s application of 500 mM sucrose dissolved in extracellular solution, and the Pvr was 
calculated as the ratio of the EPSC charge and the sucrose-evoked charge24. The antagonist 
for AMPAR-desensitization cyclothiazide (Tocris) was used at 100 µM, and the low affinity 
AMPAR antagonist ś-D-glutamylglycine (ś-DGG) at 500 µM. Data were sampled at 10 kHz 
and filtered at 3 kHz. Cultures were treated for 2–5 h with 1 µM bafilomycin A1 (Tocris, 
Bristol, UK; or Enzo Life Sciences, Farmingdale, NY, USA) before the recordings.
Hippocampal organotypic slice cultures were transferred to a submerged recording chamber 
on an upright Olympus BX51 microscope and continuously perfused with ACSF (in mM): 
125 NaCl, 25 NaHCO3, 3 KCl, 1.25 NaH2PO4, 2 CaCl2, 1 MgCl2, and 10 glucose, 
oxygenated at 95% O2 and 5% CO2. Whole-cell recordings from CA3 neurons were 
performed at room temperature with an Axon Multiclamp 700B amplifier. Intracellular 
solution contained (in mM): 135 potassium gluconate, 7 NaCl, 10 HEPES, 2 Na2ATP, 0.3 
Na-GTP and 2 MgCl2, pH adjusted to 7.2–7.3 with KOH. The stimulation electrode was 
placed in stratum radiatum and APs were triggered at 0.1 Hz. Stimulus intensities were 
adjusted to values similar to those used in control slices without treatment of Baf.
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Light delivery and live-cell imaging
In electrophysiological experiments on autaptic neurons without imaging, we activated 
pHoenix using a mercury lamp for illumination controlled by a TTL-controlled mechanical 
shutter (Uniblitz, Vincent Associates, NY, USA). Excitation light was passed through a 25% 
neutral density filter (Olympus) and a 546/10 nm excitation filter (11002v2-Green, Chroma 
Technology, Bellows Falls, VT, USA). The light intensity above the objective (Olympus 
UPLSAPO 20X, 0.75 NA) was 265 mW cm−2 at 546 nm. Similarly, organotypic 
hippocampal slices were illuminated through the objective (Olympus LumPlan FI 60X, 0.9 
NA water immersion) with a mercury lamp controlled by a TTL-driven mechanical shutter, 
using a 587/25 nm excitation filter (F20-451, AHF Analysentechnik, Tübingen, Germany).
For electrophysiology experiments and parallel imaging of pHluorin signals in autaptic 
neurons we used an Olympus UPLSAPO 60X, 1.2 NA water immersion objective. A TTL-
controlled LED system (pE2, CoolLED, Andover, UK) equipped with a 490-nm LED and a 
broadband “GYR” LED was coupled into the backport of the microscope. Excitation and 
emission light was separated by a multiband dichroic mirror (F72-628, AHF 
Analysentechnik, Tübingen, Germany). We found that band-pass filters (blue LED: 
excitation filter of the AHF Tripleband Filterset F69-402 with 495/10; GYR-LED: AHF 
F47-605 with 605/70) prevented unintended Arch3 activation by the blue LED, and allowed 
optimal Arch3-activation and minimized bleaching of pHluorin molecules by the yellow 
LED. Fluorescence signals of pHluorin molecules were bandpass filtered (AHF F73-402) 
and imaged with an EMCCD camera (iXon 897, Andor, Belfast, UK) using the 
Micromanager software59. During reacidification experiments, pHluorin signals were 
captured at 0.2 Hz, except for experiments in Supplementary Fig. 4 (0.05 Hz). After 
acquisition of baseline pHluorin signals, pHoenix was activated by a near-continuous 
illumination with the GYR-LED, which was briefly interrupted at 0.2 or 0.05 Hz by 100 ms 
flashes of the 490 nm LED. The following LED settings were applied for these imaging 
experiments: 490 nm LED set to 10–20% (50–100 mW cm−2); GYR-LED set to 100% 
(1100 mW cm−2 at 580 nm), 4.8 or 19.8 s exposure at 0.2 or 0.05 Hz respectively. GYR-
LED was set to 10% for low light intensity experiments presented in Supplementary Fig. 7. 
Intensities were measured above the objective. For the EMCCD we used the following 
settings: 100 ms exposure synchronized with the 490 nm LED, 2x2 bin, –80 °C, 4.7x 
pregain; EMgain 300 for pHoenix imaging, 100 for sypHy imaging. The same imaging setup 
was used for experiments on HEK 293 cells expressing lyso-pHoenix.
We determined the fraction of surface-resident pHoenix or sypHy molecules by applying an 
extracellular solution buffered with 10 mM MES instead of HEPES at pH 5.5, followed by 
the application of 50 mM NH4Cl containing extracellular solution with NaCl reduced to 90 
mM to maintain the osmolarity60. Images were acquired at 2 Hz during the pH 5.5 – NH4 
protocol.
Immunocytochemistry
High-density cultures of pHoenix and Arch3 expressing hippocampal neurons were fixed at 
DIV 14 with 3% (w/v) paraformaldehyde for 10–15 minutes at room temperature. Fixed 
samples were stained with primary antibodies against VGLUT1 (#135 302, Synaptic 
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Systems, Göttingen, Germany) and MAP2 (AB5543, Chemicon by Merck Millipore, 
Darmstadt, Germany) and secondary antibodies coupled to Alexa Fluor 647 or Dylight-405 
(#711-605-152 and #711-475-152, respectively, Jackson ImmunoResearch, West Grove, PA, 
USA). Stained samples were mounted in Mowiol. Fluorescent specimens were examined 
under a confocal laser-scanning microscope (TCS SP5, Leica, Wetzlar, Germany). 1024 x 
1024 pixel images were acquired using a 63X, 1.4 NA oil immersion objective and a 2–4x 
zoom.
Lyso-pHoenix transfected HeLa cells were fixed 24 h after transfection with 4% (w/v) 
paraformaldehyde for 12 minutes at room temperature or with methanol for 15 minutes at –
20 °C. The following primary antibodies were used: Primary antibodies against GFP 
(#A-11122, Life Technologies), human CD107b (lysosome-associated membrane protein-2, 
LAMP-2; #10-672-C100, HISS Diagnostics), human Rab-5 (#108011, Synaptic Systems), 
human PDI (#MA 3-019, Affinity BioReagents), human GM-130 (#610823, BD 
Biosciences) and human Hsp-60 (#611563, BD Biosiences). Secondary antibodies were 
coupled to Alexa 488 (#A11034) and Alexa 633 (#A21052, both Life Technologies, 
Molecular Probes, Carlsbad, CA, USA) respectively. For imaging, the cells were mounted 
with Aqua Poly Mount (#633736, Polysciences, Warrington, PA, USA). Images were 
acquired with a laser-scanning confocal microscope (LSM510, Carl Zeiss, Jena, Germany) 
equipped with a 63X, 1.4 NA oil immersion objective. The image size was set to 1024 x 
1024 pixels. Images for figures were processed with ImageJ software (ImageJ 1.47t; NIH, 
USA) to enhance brightness using the brightness/contrast function. Immunocytochemistry 
experiments were repeated two to three times.
Data collection and analysis
Viral particles encoding controls and pHoenix constructs were randomly applied on different 
wells of the same 6- or 12 well plates from the same culture. From each culture, wells were 
randomly subjected to treatment or control conditions, and recordings from multiple groups 
were performed on the same day, in a randomized order. Data collection and analysis were 
not performed blind to the conditions of the experiments.
Electrophysiological recordings were analyzed using the AxographX software. For mEPSC 
analysis, we used the implemented scaled template detection algorithm for recordings that 
had been filtered once post-hoc with a 1 kHz low-pass filter. False-positive events were 
estimated by running the spontaneous event detection with an inverted template61. 
Frequency and amplitude of mEPSCs were corrected for false-positives, and recordings with 
false-positive events of > 2 Hz were excluded.
Images of pHluorin signals were analyzed using ImageJ and the Time Series Analyzer V2.0 
plug-in. Fluorescence intensities were calculated from 2x2 pixel regions of interest (ROI) 
drawn on synaptic contacts, which were identified as small structures with a dynamic 
increase of fluorescence evoked by NH4 application. Background fluorescence from a region 
with no neuronal structures was subtracted for each frame.
Colocalization of lyso-pHoenix and organelle markers was analyzed using the CellProfiler 
2.1.1 program (Broad Institute of MIT and Harvard)62. In a pixel-based approach the 
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colocalization of two channels was calculated after the images were aligned. For every co-
staining ten cells were analyzed and the Pearson’s correlation coefficient was determined.
Data are presented as mean ± SEM and were tested for normality using the D'Agostino and 
Pearson omnibus normality test. Sample sizes were not predetermined by statistical 
methods, but are similar to those reported in comparable previous publications15. Time 
constants were calculated from fitting the data as monoexponential decay or association 
using GraphPad Prism 5. Differences between two groups were tested for significance by 
unpaired or paired two-way Student’s t-tests. If data did not pass the normality test we 
applied a Mann-Whitney U test for unpaired and a Wilcoxon signed-rank test for paired 
data. For multiple comparisons of EPSC amplitudes and mEPSC frequencies in 
Supplementary Fig. 5, we used repeated measures two-way ANOVA with Sidak's multiple 
comparisons post-test, and a regular two-way ANOVA with Sidak's multiple comparisons 
post-test for comparisons of mEPSC amplitudes (due to three Baf-treated cells without 
detectable mEPSCs in the pre-light condition, repeated measures two-way ANOVA could 
not be performed for mEPSC amplitudes). Number of cells (n) and number of cultures (N) 
are reported in the figure legends. Statistics were calculated using GraphPad Prism 5 and 6.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Design and localization of the light-driven vesicular proton pump pHoenix.
(a) Membrane topology of the pHoenix construct. ŚHK: H+/K+ ATPase beta-subunit. (b) 
Confocal images displaying a dendritic segment of a neuron expressing pHoenix or Arch3-
eGFP (green), counterstained for the presynaptic marker VGLUT1 (magenta) and the 
dendritic marker MAP2 (blue). Scale bar, 3 µm. (c) Membrane currents evoked by brief light 
applications in Arch3- (upper trace; scale bar, 500 pA) or pHoenix-expressing neurons 
(lower trace; scale bars, 500 ms, 50 pA). Arch3-positive cells showed currents of 0.9 ± 0.1 
nA (n = 13, N = 2), while in pHoenix-positive cells light triggered only small currents (3.6 
± 2.1 pA, n = 8, N = 2; P = 0.0002, Mann-Whitney U test, U = 0). (d) Surface fractions of 
sypHy and pHoenix at synaptic terminals were 0.17 ± 0.02 for sypHy (n = 16) compared to 
0.15 ± 0.02 for pHoenix (n = 12, N = 3; P = 0.7, unpaired two-tailed t-test, t26 = 0.378). (e) 
Exocytosis triggered by 60 APs at 20 Hz increased pHluorin signals due to membrane fusion 
of pHoenix-containing synaptic vesicles (n = 11, N = 4).
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Fig. 2. pHoenix can substitute for V-ATPase function.
(a) pHluorin signals of a pHoenix-expressing, Baf-treated neuron acquired before (time 
point – 10 and 0 s) and during (10 and 20 s) pHoenix activation. Arrowheads indicate 
synaptic contacts. Scale bar, 10 µm. (b) EPSCs recorded from a Baf-treated neuron at 
indicated time points during pHoenix activation. Scale bars, 5 ms and 1nA. (c) Time-plot of 
normalized pHluorin signals and normalized EPSCs recorded in parallel from Baf-treated, 
pHoenix-expressing cells (n = 15, N = 2). Fluorescence of pHluorin molecules was imaged 
at 0.2 Hz using 100 ms flashes of a 490 nm LED (dotted blue line), just before APs were 
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triggered. Vesicle acidification by pHoenix and transmitter uptake was induced by interlaced 
illumination with yellow light.
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Fig. 3. Activation of pHoenix in untreated neurons increases the quantal size
(a) Averages of four EPSCs recorded before and at the end of the 2 min illumination period 
from a control and a pHoenix-expressing neuron. Scale bars, 5 ms and 2 nA. Illumination 
had no effect on EPSCs evoked at 0.1 Hz in control neurons (0.1 ± 2%, n = 19, N = 7), but 
increased EPSCs in pHoenix expressing neurons by 13 ± 2% (n = 24, N = 7; P < 0.0001, 
Mann-Whitney U test; U = 55). (b) Example traces of paired EPSCs evoked at 40 ms inter-
stimulus interval. Amplitudes normalized to the 1st EPSC. Scale bar, 10 ms. Paired-pulse 
ratio changes were not different between the control and pHoenix group (P = 0.1, two-tailed 
Mann-Whitney U test, U = 159). (c) Spontaneous quantal release events were analyzed from 
a 1 min period preceding light and the second minute of illumination. Light did not alter the 
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frequency of mEPSCs (Control cells: baseline (BL): 14.1 ± 2.3 Hz, light: 14.5 ± 2.2 Hz; n = 
16, N = 7; P = 0.5, paired two-tailed t-test, t15 = 0.701; pHoenix cells: BL = 9.9 ± 1.2 Hz, 
light: 11.2 ± 1.4 Hz; n = 17, N = 7; P = 0.1, paired two-tailed t-test, t16 = 1.809. Scale bar, 
200 ms and 50 pA. The mEPSC frequency change in pHoenix expressing cells was not 
significantly different to control neurons (P = 0.2, Mann-Whitney U test, U = 102). (d) 
mEPSC amplitudes increased significantly in pHoenix expressing neurons (BL: 32.4 ± 2.1 
pA, light: 35.9 ± 2.3 pA, n = 17, N = 7; P < 0.0001, paired two-tailed t-test, t16 = 5.719), but 
were not significantly altered in control cells (BL: 29.2 ± 1.6 pA, light: 30.6 ± 1.9 pA; n = 
16, N = 7; P = 0.13, paired two-tailed t-test, t15 = 1.596). Scale bars, 5 ms, 10 pA. The 
increase of mEPSC amplitudes in pHoenix-positive neurons was significantly different to 
controls (P = 0.02, Mann-Whitney U test, U = 72). (e) Correlation of the EPSC and mEPSC 
amplitude increase from pHoenix-expressing neurons. Pearson correlation, two-tailed: P = 
0.04, R2 = 0.25; n = 17, N = 7. There was no correlation between the EPSC increase and the 
change in mEPSC frequency (Pearson correlation, two-tailed: P = 0.25, R2 = 0.09; 
correlation not shown).
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Fig. 4. Neurons with residual glutamate release after Baf-treatment have smaller mEPSCs and a 
high paired-pulse ratio.
(a) Residual EPSC of a neuron incubated for 165 min in Baf (baseline, gray trace), which 
increased to 400% after pHoenix activation (full, black trace). Scale bars, 5 ms, 0.5 nA. 
EPSC recovery shown for 20 cells with residual release (0.3 ± 0.1 nA before, 5.5 ± 0.9 nA 
after illumination, Ŭ = 66 s; N = 7). (b) Average mEPSCs and example trace of mEPSCs 
recorded from a neuron before (gray) and after (black) activation of pHoenix. Scale bars, 
left: 5 ms and 10 pA; right: 100 ms and 50 pA. mEPSC amplitudes increased from 17 ± 2 to 
29 ± 3 pA, and mEPSC frequency increased from 0.7 ± 0.2 to 8.1 ± 1.7 Hz (n = 15, N = 7, 
amplitudes: P < 0.0001, paired two-tailed t-test, t14 = 5.847; frequency: P < 0.0001, 
Wilcoxon signed-rank test, W = –120). (c) Paired EPSCs evoked at 40 ms interval during 
baseline and after pHoenix activation. Amplitudes scaled to first EPSC. Scale bar, 5 ms. 
Time course of the paired-pulse ratio change from the same cells as in (a). PPR decreased 
from 1.5 ± 0.1 to 1.1 ± 0.1, with Ŭ = 23 s.
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Fig. 5. Partially filled vesicles have a lower release probability.
(a) Interval activation of pHoenix allows titration of EPSCs from a depleted to an 
intermediate and full recovery state. Scale bars, 5 ms, 200 pA. EPSCs recovered during the 
30 s of pHoenix activation to 0.7 ± 0.1 nA, remained stable during the intermediate dark 
phase, and further increased over the following 90 s of illumination to 1.9 ± 0.2 nA (n = 26, 
N = 6, P < 0.0001, Wilcoxon signed-rank test, W = –351). (b) Averages of mEPSCs detected 
during intermediate (gray) and full recovery condition (black), and typical mEPSC 
recordings from the same cell. Scale bars, left: 5 ms, 10 pA; right: 200 ms, 25 pA. mEPSC 
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amplitudes increased from 18.6 ± 1.2 to 24.9 ± 1.3 pA (n = 21, N = 6; P < 0.0001, paired 
two-tailed t-test, t20 = 9.811), while the frequency increased from 3.5 ± 0.8 to 6.0 ± 1.0 Hz 
(P = 0.0002, Wilcoxon signed-rank test, W = –217). (c) Attenuation of EPSCs by the 
application of ś-DGG. EPSCs scaled to EPSCs before drug application. Scale bar, 5 ms. ś-
DGG application caused an instantaneous drop of EPSC amplitudes (n = 10; N = 2). The 
EPSC reduction was stronger during the intermediate fill state compared to the full recovery 
state (P = 0.003, paired two-tailed t-test, t9 = 4.155). (d) Average traces of paired EPSCs 
during intermediate and full recovery condition, normalized to the 1st EPSC. Scale bar, 10 
ms. PPR time course during the interval recovery protocol, normalized to the period after the 
2nd light interval. During the intermediate recovery state, average PPR was significantly 
higher compared to the PPR after full recovery (intermediate: 1.22 ± 0.04, full: 1.14 ± 0.04; 
n = 26, N = 6; P = 0.004, paired two-tailed t-test, t25 = 3.222). (e) Postsynaptic response 
elicited by application of 500 mM sucrose after intermediate and full recovery of 
transmission. Averages of EPSCs recorded after the first and the second light interval are 
shown for comparison. Scale bars, 10 ms, 1 nA for EPSCs; 1 s, 1 nA for sucrose responses 
(f) Hypertonic sucrose solution was applied after the first and second light interval, at time 
points indicated by arrows. EPSC amplitudes recovered after the depletion of the RRP (n = 
15, N = 4). (g) The RRP increases from 290 ± 50 pC to 730 ± 130 pC (P = 0.0002, paired 
two-tailed t-test, t14 = 5.116). (h) The Pvr increases from 1.4 ± 0.2% to 1.7 ± 0.2% (P = 0.02, 
paired two-tailed t-test, t14 = 2.665). (i) EPSC charge, RRP and Pvr during the intermediate 
state normalized to the full recovery state. (j) The increase of the EPSC from the 
intermediate to the full recovery state correlates with the increase of the RRP (Pearson 
correlation, P < 0.0001, R2 = 0.75) and the Pvr (Spearman correlation, P = 0.003).
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Fig. 6. Optogenetic acidification of lysosomes.
(a) Schematic of the lyso-pHoenix construct, with CD63 flanking Arch3, the fluorophores 
and the ŚHK transmembrane domain. (b) Confocal images of a HeLa cell expressing lyso-
pHoenix (green, signal enhanced by anti-GFP antibody), stained for LAMP-2 (magenta), 
and the nucleus stained with DAPI. Scale bar, 10 µm. (c) Quantification of lyso-pHoenix 
colocalization with different organelle marker proteins (n = 10, N = 2). Lyso-pHoenix shows 
a high degree of colocalization with the lysosome marker LAMP-2, but not with markers for 
the cis-Golgi (GM130), endoplasmic reticulum (PDI), mitochondria (Hsp60) and endosomes 
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(Rab5). Analyzed by one-way ANOVA, with Tukey’s multiple comparison test: P < 0.001 
for LAMP-2 vs. all other markers, F(4,45) = 203.6. (d) Images of a Baf-treated HEK 293 
cell acquired before, during and after activation of lyso-pHoenix (averages of two frames). 
Scale bar, 10 µm. Illumination rapidly decreases pHluorin signals due to lysosomal 
acidification (n = 18, N = 2). This effect is not seen in Baf-treated cells expressing CD63-
pHluorin (n = 15, N = 2).
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